Molecules detected on the GSCs included those associated with the cancer stem cell phenotype (CD24, CD44 and CD90) (Fig. 3a), as well as widely expressed cell surface molecules, such as major histocompatibility complex (MHC) class I (and β2‐microglobulin), CD71 and CD98, as expected. The gene discussed is HLA-G; the disease is cancer.